Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

21 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Recognition and treatment of BCG failure in bladder cancer.
Lightfoot AJ, Rosevear HM, O'Donnell MA. Lightfoot AJ, et al. ScientificWorldJournal. 2011 Mar 7;11:602-13. doi: 10.1100/tsw.2011.30. ScientificWorldJournal. 2011. PMID: 21399857 Free PMC article.
Current and future need for academic urologists in the United States.
Lightfoot AJ, Rosevear HM, Steers WD, Tracy CR. Lightfoot AJ, et al. J Urol. 2011 Jun;185(6):2283-7. doi: 10.1016/j.juro.2011.02.058. Epub 2011 Apr 17. J Urol. 2011. PMID: 21497844
Factors affecting response to bacillus Calmette-Guérin plus interferon for urothelial carcinoma in situ.
Rosevear HM, Lightfoot AJ, Birusingh KK, Maymí JL, Nepple KG, O'Donnell MA; National BCG/Interferon Investigator Group. Rosevear HM, et al. Among authors: lightfoot aj. J Urol. 2011 Sep;186(3):817-23. doi: 10.1016/j.juro.2011.04.073. Epub 2011 Jul 23. J Urol. 2011. PMID: 21788050 Clinical Trial.
Role of routine transurethral biopsy and isolated upper tract cytology after intravesical treatment of high-grade non-muscle invasive bladder cancer.
Lightfoot AJ, Rosevear HM, Nepple KG, O'Donnell MA. Lightfoot AJ, et al. Int J Urol. 2012 Nov;19(11):988-93. doi: 10.1111/j.1442-2042.2012.03089.x. Epub 2012 Jul 4. Int J Urol. 2012. PMID: 22762480 Free article.
Multi-institutional analysis of sequential intravesical gemcitabine and mitomycin C chemotherapy for non-muscle invasive bladder cancer.
Lightfoot AJ, Breyer BN, Rosevear HM, Erickson BA, Konety BR, O'Donnell MA. Lightfoot AJ, et al. Urol Oncol. 2014 Jan;32(1):35.e15-9. doi: 10.1016/j.urolonc.2013.01.009. Epub 2013 Mar 17. Urol Oncol. 2014. PMID: 23510863 Free PMC article. Clinical Trial.
Rubin H. Flocks and colloidal gold treatments for prostate cancer.
Rosevear HM, Lightfoot AJ, O'Donnell MA, Platz CE, Loening SA, Hawtrey CE. Rosevear HM, et al. Among authors: lightfoot aj. ScientificWorldJournal. 2011;11:1560-7. doi: 10.1100/tsw.2011.145. Epub 2011 Aug 16. ScientificWorldJournal. 2011. PMID: 22224070 Free PMC article.
Index of Suspicion * Case 1: Voiding difficulty in a 10-year-old * Case 2: Seizure-like activity precipitated by loud noise in a 2-year-old * Case 3: purplish-brown, shiny upper extremity lesion and stiff hand in a 9-year-old.
Rosevear HM, Lightfoot AJ, Powell CR, Weisleder P, Vidaurre J, Lehman N, Moorthy LN. Rosevear HM, et al. Among authors: lightfoot aj. Pediatr Rev. 2011 Oct;32(10):447-52. doi: 10.1542/pir.32-10-447. Pediatr Rev. 2011. PMID: 21965712 No abstract available.
Usefulness of the Spanish Urological Club for Oncological Treatment scoring model to predict nonmuscle invasive bladder cancer recurrence in patients treated with intravesical bacillus Calmette-Guérin plus interferon-α.
Rosevear HM, Lightfoot AJ, Nepple KG, O'Donnell MA. Rosevear HM, et al. J Urol. 2011 Jan;185(1):67-71. doi: 10.1016/j.juro.2010.08.083. Epub 2010 Nov 12. J Urol. 2011. PMID: 21074202 Clinical Trial.
Bacillus Calmette-Guérin with or without interferon α-2b and megadose versus recommended daily allowance vitamins during induction and maintenance intravesical treatment of nonmuscle invasive bladder cancer.
Nepple KG, Lightfoot AJ, Rosevear HM, O'Donnell MA, Lamm DL; Bladder Cancer Genitourinary Oncology Study Group. Nepple KG, et al. J Urol. 2010 Nov;184(5):1915-9. doi: 10.1016/j.juro.2010.06.147. Epub 2010 Sep 17. J Urol. 2010. PMID: 20846688 Clinical Trial.
Safety and efficacy of intravesical bacillus Calmette-Guérin plus interferon α-2b therapy for nonmuscle invasive bladder cancer in patients with prosthetic devices.
Rosevear HM, Lightfoot AJ, Nepple KG, O'Donnell MA. Rosevear HM, et al. J Urol. 2010 Nov;184(5):1920-4. doi: 10.1016/j.juro.2010.06.149. Epub 2010 Sep 17. J Urol. 2010. PMID: 20846678 Clinical Trial.
21 results
Jump to page
Feedback